Document and Entity Information
Document and Entity Information | May 07, 2024 |
Cover [Abstract] | |
Amendment Flag | false |
Entity Central Index Key | 0001817713 |
Document Type | 8-K |
Document Period End Date | May 07, 2024 |
Entity Registrant Name | Janux Therapeutics, Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-40475 |
Entity Tax Identification Number | 82-2289112 |
Entity Address, Address Line One | 10955 Vista Sorrento Parkway |
Entity Address, Address Line Two | Suite 200 |
Entity Address, City or Town | San Diego |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92130 |
City Area Code | 858 |
Local Phone Number | 751-4493 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, $0.001 par value per share |
Trading Symbol | JANX |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | true |